Creative Medical Technology Holdings Inc (CELZ) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Over the past 4 years, Creative Medical Technology Holdings Inc has achieved a revenue compound annual growth rate (CAGR) of -49.1%, while earnings have grown at -37.6% CAGR.
Historical revenue and profitability trends for Creative Medical Technology Holdings Inc
The chart above illustrates Creative Medical Technology Holdings Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Creative Medical Technology Holdings Inc's business.
How efficiently Creative Medical Technology Holdings Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Creative Medical Technology Holdings Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Creative Medical Technology Holdings Inc to continue growing earnings in the coming year. The consensus analyst rating is 4 based on 1 analyst.
Based on our comprehensive analysis, Creative Medical Technology Holdings Inc (CELZ) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Creative Medical Technology Holdings Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Creative Medical Technology Holdings Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: CELZ Valuation, CELZ Dividend, CELZ Financial Health
Compare: CELZ vs AAPL, CELZ vs MSFT, CELZ vs GOOGL